RT Journal Article
SR Electronic
T1 Multi-ancestry Genome Wide Association Study Meta-analysis of Non-syndromic Orofacial Clefts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.12.06.24318522
DO 10.1101/2024.12.06.24318522
A1 Jia, Zhonglin
A1 Mukhopadhyay, Nandita
A1 Yang, Zhenglin
A1 Butali, Azeez
A1 Sun, Jialin
A1 You, Yue
A1 Yao, Meilin
A1 Zhen, Qi
A1 Ma, Jian
A1 He, Miao
A1 Pan, Yongchu
A1 Alade, Azeez
A1 Wang, Yirui
A1 Olujitan, Mojisola
A1 Qi, Mengchun
A1 Adeyemo, Wasiu Lanre
A1 Buxó, Carmen J.
A1 Gowans, Lord J.J
A1 Eshete, Mekonen
A1 Huang, Yongqing
A1 Li, Chenghao
A1 Leslie, Elizabeth J.
A1 Wang, Lin
A1 Bian, Zhuan
A1 Carlson, Jenna C.
A1 Shi, Bing
A1 Weinberg, Seth M.
A1 Murray, Jeffrey C.
A1 Sun, Liangdan
A1 Marazita, Mary L.
A1 Freathy, Rachel M.
A1 Beaumont, Robin N.
YR 2024
UL http://medrxiv.org/content/early/2024/12/13/2024.12.06.24318522.abstract
AB Non-syndromic orofacial clefts (NSOC) are common craniofacial birth defects, and result from both genetic and environmental factors. NSOC include three major sub-phenotypes: non-syndromic cleft lip with palate (NSCLP), non-syndromic cleft lip only (NSCLO) and non-syndromic cleft palate only (NSCPO), NSCLP and NSCLO are also sometimes grouped as non-syndromic cleft lip with or without cleft palate (NSCL/P) based on epidemiology. Currently known loci only explain a limited proportion of the heritability of NSOC. Further, differences in genetic susceptibility among the sub-phenotypes are poorly characterized. We performed a multi-ancestry GWAS meta-analysis on 44,094 individuals (9,381 cases, 28,510 controls, 2042 case-parent trios and 18 multiplex pedigrees) of East Asian, European, Latin and South American, and African ancestry for both NSOC and subtypes. We identified 50 loci, including 11 novel loci: four loci (CALD1, SHH, NRG1 and LINC00320) associated with both NSOC and NSCL/P, two loci (NTRK1 and RUNX1) only associated with NSOC, four loci (HMGCR, PRICKLE1, SOX9 and MYH9) only associated with NSCL/P and one locus (ALX1) specifically associated with NSCLO. Five of the novel loci are located in regions containing genes associated with syndromic orofacial clefts (SHH, NTRK1, CALD1, ALX1 and SOX9); seven of the novel loci are located in regions containing genes implicated in craniofacial development (HMGCR, SHH, PRICKLE1, ALX1, SOX9, RUNX1, MYH9). Genetic correlation and colocalization analyses revealed an overlap between signals associated with NSCLO, NSCPO and NSCLP, but there were also notable differences, emphasizing the complexity of common and distinct genetic processes affecting lip and palate development.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by the National Science Funds of China (No.81271118, No. 81600849), Sichuan Province Science and Technology support program (No.2024NSFSC0649), the Research and Develop Program, West China Hospital of Stomatology Sichuan University (No. RD-03-202301); R.M.F. was supported by a Wellcome Senior Fellowship (WT220390). This research was funded in part, by the Wellcome Trust [Grant number WT220390]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any author accepted manuscript version arising from this submission; Liangdan Sun was supported by Hebei Natural Science Foundation H2023209084 and S&T Program of Hebei 23372505D; Miao He was supported by the Joint Funds of the National Natural Science Foundation of China (No. U22A20313); Yongchu Pan was supported by the National Natural Science Foundation of China (82270496) and Key Research and Development Program of Jiangsu Province (BE2023831); Zhuan Bian was supported by the National Natural Science Foundation of China (No.82170944, No.81970923, No.82370966); The POFC1 cohorts were recruited and genotyped through grant support from the United States National Institutes of Health (NIH): grant numbers R01-DE016148, R01-DE008559, X01-HG000784.The GENEVA cohorts were genotyped through NIH grant support: grant number U01-DE-018993.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional review boards of Sichuan University,Anhui Medical University,Wuhan University,Nanjing Medical University,University of Pittsburgh,University of Iowa,University of Lagos and Kwame Nkurumah University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll results produced in the present study are available upon reasonable request to the authors